- Home
- PROK vs APEI Comparison
PROK vs APEI Comparison
Compare PROK & APEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- APEI
- Stock Information
- Founded
- PROK 2015
- APEI 1991
- Country
- PROK United States
- APEI United States
- Employees
- PROK N/A
- APEI N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- APEI Other Consumer Services
- Sector
- PROK Health Care
- APEI Consumer Discretionary
- Exchange
- PROK Nasdaq
- APEI Nasdaq
- Market Cap
- PROK 211.1M
- APEI 383.8M
- IPO Year
- PROK N/A
- APEI 2007
- Fundamental
- Price
- PROK $1.63
- APEI $21.97
- Analyst Decision
- PROK Buy
- APEI Buy
- Analyst Count
- PROK 5
- APEI 4
- Target Price
- PROK $4.50
- APEI $21.00
- AVG Volume (30 Days)
- PROK 409.2K
- APEI 77.3K
- Earning Date
- PROK 03-21-2025
- APEI 03-04-2025
- Dividend Yield
- PROK N/A
- APEI N/A
- EPS Growth
- PROK N/A
- APEI N/A
- EPS
- PROK N/A
- APEI 0.56
- Revenue
- PROK N/A
- APEI $613,253,000.00
- Revenue This Year
- PROK N/A
- APEI $5.70
- Revenue Next Year
- PROK N/A
- APEI $4.20
- P/E Ratio
- PROK N/A
- APEI $39.28
- Revenue Growth
- PROK N/A
- APEI 2.18
- 52 Week Low
- PROK $1.18
- APEI $10.30
- 52 Week High
- PROK $4.44
- APEI $23.84
- Technical
- Relative Strength Index (RSI)
- PROK 46.75
- APEI 56.42
- Support Level
- PROK $1.57
- APEI $21.25
- Resistance Level
- PROK $1.77
- APEI $22.30
- Average True Range (ATR)
- PROK 0.12
- APEI 0.78
- MACD
- PROK -0.00
- APEI 0.03
- Stochastic Oscillator
- PROK 39.06
- APEI 65.03
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.
About APEI American Public Education Inc.
American Public Education Inc provides online and on-campus postsecondary education including various undergraduate and graduate degree programs. The fields of study include business administration, health science, technology, criminal justice, education, liberal arts, national security, military studies, intelligence, and homeland security. There are three reporting segments: the American Public University segment which is the key revenue generator; the Rasmussen University Segment and the Hondros College of Nursing segment. The revenue is generated from net course registrations and enrollment, tuition rate, net tuition, and other fees.